Medicare Enrolled

Dr. Charles Asta, M.D.

Neurology · Teaneck, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1 DEGRAW AVE STE B, Teaneck, NJ 07666
2018558300
Registered in NPPES since 2006
NPI: 1245314806 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Asta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Asta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Asta

Dr. Charles Asta is a neurology specialist in Teaneck, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Asta performed 11,243 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Asta received a total of $54,588 from 92 pharmaceutical and/or device companies across 1369 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Asta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 7% volume in NJ $54,588 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
11,243
Medicare services
Top 7% in NJ for neurology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
10,327 $5 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
540 $105 $270
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
81 $126 $447
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
78 $75 $179
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
34 $124 $675
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
30 $79 $355
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
30 $112 $650
Additional hour of neuropsychological test evaluation
This code covers the evaluation of neuropsychological testing for each additional hour beyond the initial service. It represents the time spent analyzing and interpreting test results.
30 $85 $510
Psychological or neuropsychological test, first 30 minutes
Administration of psychological or neuropsychological testing for the first 30 minutes.
30 $38 $260
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
29 $144 $375
Continuous EEG brain wave monitoring
A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously.
12 $175 $520
Video EEG monitoring, 2-12 hours
Continuous monitoring of brain wave activity combined with video recording for a duration of 2 to 12 hours.
11 $470 $1,810
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
11 $107 $410
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$54,588
Total received (2018-2024)
Avg $7,798/year across 7 years
Top 8% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
1,369
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,492
2023
$10,047
2022
$10,215
2021
$17,833
2020
$3,217
2019
$3,307
2018
$1,476

Payments by company (2024)

ABBVIE INC.
$4,917
Eisai Inc.
$363
Lundbeck LLC
$303
MDD US Operations, LLC
$300
PFIZER INC.
$298
Lilly USA, LLC
$267
Teva Pharmaceuticals USA, Inc.
$201
SK Life Science, Inc.
$162
Kyowa Kirin, Inc.
$145
Novartis Pharmaceuticals Corporation
$143
E.R. Squibb & Sons, L.L.C.
$125
SCILEX PHARMACEUTICALS INC.
$105
UCB, Inc.
$100
Amneal Pharmaceuticals LLC
$92
EMD Serono, Inc.
$90
Otsuka America Pharmaceutical, Inc.
$86
Alexion Pharmaceuticals, Inc.
$82
ARGENX US, INC.
$69
Celgene Corporation
$67
Supernus Pharmaceuticals, Inc.
$61
Alnylam Pharmaceuticals Inc.
$57
Biogen, Inc.
$52
Genentech USA, Inc.
$46
Neurocrine Biosciences, Inc.
$45
Life Molecular Imaging Ltd
$44
Xeris Pharmaceuticals, Inc.
$42
Azurity Pharmaceuticals, Inc.
$36
CSL Behring
$31
GE HEALTHCARE
$29
Ipsen Biopharmaceuticals, Inc
$28
Takeda Pharmaceuticals U.S.A., Inc.
$23
Merz Pharmaceuticals, LLC
$19
Amgen Inc.
$18
AstraZeneca Pharmaceuticals LP
$16
Axsome Therapeutics, Inc.
$16
ACADIA Pharmaceuticals Inc
$15
Top 3 companies account for 65.8% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$19,499
ABBVIE INC.
$11,394
Allergan, Inc.
$3,963
Teva Pharmaceuticals USA, Inc.
$1,777
Lilly USA, LLC
$1,250
Boston Scientific Corporation
$1,238
Amgen Inc.
$1,205
Lundbeck LLC
$831
Neurocrine Biosciences, Inc.
$764
EMD Serono, Inc.
$726
Amneal Pharmaceuticals LLC
$589
Biogen, Inc.
$571
PFIZER INC.
$571
Eisai Inc.
$563
Genentech USA, Inc.
$561
Adamas Pharmaceuticals, Inc.
$510
Novartis Pharmaceuticals Corporation
$500
Kyowa Kirin, Inc.
$469
MDD US Operations, LLC
$401
Biohaven Pharmaceuticals, Inc.
$391
SK Life Science, Inc.
$368
GENZYME CORPORATION
$342
Janssen Pharmaceuticals, Inc
$308
Alnylam Pharmaceuticals Inc.
$299
E.R. Squibb & Sons, L.L.C.
$295
Alexion Pharmaceuticals, Inc.
$282
Celgene Corporation
$264
Allergan Inc.
$232
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$227
ACADIA Pharmaceuticals Inc
$207
Avanir Pharmaceuticals, Inc.
$194
SCILEX PHARMACEUTICALS INC.
$173
JAZZ PHARMACEUTICALS INC.
$170
EISAI INC.
$166
UCB, Inc.
$165
Biohaven Pharmaceutical Holding Company Ltd.
$162
Otsuka America Pharmaceutical, Inc.
$158
Scilex Pharmaceuticals Inc.
$151
Almatica Pharma LLC
$135
ARGENX US, INC.
$115
Supernus Pharmaceuticals, Inc.
$114
UPSHER-SMITH LABORATORIES LLC
$109
Synergy Pharmaceuticals Inc
$100
Merz Pharmaceuticals, LLC
$97
CSL Behring
$97
Grifols USA, LLC
$96
Takeda Pharmaceuticals U.S.A., Inc.
$92
Azurity Pharmaceuticals, Inc.
$80
Mitsubishi Tanabe Pharma America, Inc.
$78
Avion Pharmaceuticals
$72
GE HEALTHCARE
$72
Currax Pharmaceuticals LLC
$70
Acorda Therapeutics, Inc
$69
AstraZeneca Pharmaceuticals LP
$66
Bausch Health US, LLC
$66
Axsome Therapeutics, Inc.
$64
IMPEL PHARMACEUTICALS INC.
$59
GE Healthcare
$52
MITSUBISHI TANABE PHARMA AMERICA, INC.
$50
Merck Sharp & Dohme LLC
$45
TG THERAPEUTICS, INC.
$44
Life Molecular Imaging Ltd
$44
Xeris Pharmaceuticals, Inc.
$42
Upsher-Smith Laboratories LLC
$42
IDORSIA PHARMACEUTICALS US INC
$41
Mallinckrodt Hospital Products Inc.
$40
Sunovion Pharmaceuticals Inc.
$36
Jazz Pharmaceuticals Inc.
$35
Medtronic USA, Inc.
$35
Olympus America Inc.
$35
BOSTON SCIENTIFIC CORPORATION
$34
BIOTRONIK INC.
$33
GE HealthCare
$32
Mallinckrodt Enterprises LLC
$31
Adlon Therapeutics L.P.
$30
Impax Laboratories, Inc.
$29
Ipsen Biopharmaceuticals, Inc
$28
Collegium Pharmaceutical, Inc.
$28
AbbVie, Inc.
$27
Octapharma USA, Inc.
$26
Assertio Therapeutics, Inc.
$16
Arbor Pharmaceuticals, Inc.
$16
Amylyx Pharmaceuticals, Inc.
$15
Optinose US, Inc.
$15
Aprecia Pharmaceuticals, LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Horizon Therapeutics plc
$14
Merck Sharp & Dohme Corporation
$14
Zyla Life Sciences
$13
Vertical Pharmaceuticals, LLC
$12
ASSERTIO THERAPEUTICS, INC.
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 63.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADHANSIA XR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · Auvelity · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREXONT · Cambia · DUEXIS · DUOPA · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · Enspryng · Eprontia · Fycompa · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MIGRANAL · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · ONZETRA Xsail · Ocrevus · Ocrevus Zunovo · Olympus ENT Fiber Scopes · Ongentys · PANZYGA · PAXLOVID · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qelbree · RADICAVA · RELEXXII · RELYVRIO · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Soliris · Spritam · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TRULANCE · TYSABRI · Trudhesa · Trulance · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · XCOPRI · Xeomin · Xhance · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Teaneck?
Compare neurologists in the Teaneck area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
1,261
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
HOLY NAME MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Asta is a mixed practice specialist, with above-average Medicare volume (top 7% in NJ), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Asta experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Asta performed 10,327 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Asta receive payments from pharmaceutical companies?
Yes. Dr. Asta received a total of $54,588 from 92 companies across 1,369 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Asta's costs compare to other neurologists in Teaneck?
Dr. Asta's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Asta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →